Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
Chris Markoch

DARK SECRETS: 3 biotech stocks that look like sure fire winners in 2026 | Vintage Vibes

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk. The success of these companies depends on clinical trial results, regulatory decisions, and their ability to scale these drugs once they get approved. Even the best ideas can fail trials or face delays.

Despite the elevated risks, it just takes a single drug reaching FDA approval to generate significant returns for investors. Many of these names start as penny stocks, so betting on a winner is like buying a lucky lottery ticket—and this is what keeps investors looking for opportunities in the biotech space.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.